Enjoy complimentary customisation on priority with our Enterprise License!
The bone wax market size is forecast to increase by USD 19.2 million, at a CAGR of 4.44% between 2023 and 2028. The market is expanding due to several pivotal factors. The growing prevalence of orthopedic conditions and an increase in surgical cases drive demand for advanced medical solutions. Additionally, the rise in sports and recreation-related injuries further propels the need for effective orthopedic treatments and interventions. A significant trend is the steep rise in the adoption of absorbable bone wax products, which are crucial for managing bone healing and preventing complications in surgical procedures. These factors collectively contribute to market growth, as healthcare providers and patients seek innovative solutions to address orthopedic challenges and enhance recovery outcomes. The convergence of rising injury rates, surgical needs, and advanced product adoption underscores the dynamic nature of the market.
For More Highlights About this Report, Request Free Sample
The market is witnessing significant growth due to the increasing prevalence of bone health issues, particularly osteoporosis. The Osteoporosis Foundation estimates that over 54 million Americans have low bone density or osteoporosis. Bone wax, a medical device used to prevent bone grafts from collapsing during orthopedic surgeries like hip arthroplasty, plays a crucial role in bone repair. Two main types of bone wax exist: absorbable and non-absorbable. Absorbable bone wax, such as Asid Bonz, dissolves over time, allowing new bone growth. Non-absorbable bone wax, like Hemostax, remains in the body permanently. Both types are used in various orthopedic and dental surgeries, including arthroplasty procedures.
Moreover, the market expansion strategy includes partnerships with hospitals and outpatient facilities. Key players in the market include Tableau Wax, Orion Biotech, and others. The National Safety Council and emergency departments use bone wax for trauma cases, while the World Health Organization emphasizes its importance in brain injury and sports-related injuries. Bone wax's applications extend beyond orthopedic and dental surgeries. It is also used in biotechnological products and healthcare players' research and development. The market is expected to grow further due to the increasing number of arthroplasty procedures and the rising awareness of bone health.
Growing orthopedic conditions and surgical cases is notably driving market growth. Every year, approximately 37.3 million severe falls worldwide necessitate medical intervention, leading to substantial medical expenses, with the US incurring over USD50 billion for both fatal and non-fatal fall-related costs. The healing process for fractured bones can be lengthy, making hemostatic products, such as bone wax, increasingly essential. The Arthritis Foundation anticipates that by 2050, 130 million individuals globally will be diagnosed with degenerative joint diseases like osteoarthritis, further driving the demand for bone healing solutions. Ambulatory Surgical Centers (ASCs) have gained popularity due to their cost-effective day surgical services, attracting patients seeking to minimize hospital stays.
However, some patients with orthopedic conditions still opt for inpatient departments based on the nature of their injuries. The global bone wax market is expected to expand significantly due to the increasing prevalence of bone injuries and degenerative diseases. One of the leading hemostatic products in the market is Oxidized Regenerated Cellulose (ORC), which includes brands like Dolphin Hemostats. These products effectively manage bleeding during surgical procedures, ensuring optimal patient outcomes. Thus, such factors are driving the growth of the market during the forecast period.
Growing adoption of minimally invasive orthopedic surgeries is the key trend in the market. The market for hemostatic products, such as Oxidized Regenerated Cellulose (ORC), is experiencing significant growth due to the increasing adoption of minimally invasive surgeries. Minimally invasive procedures offer numerous advantages, including shorter hospital stays, reduced pain and discomfort, lower infection and bleeding risks, smaller scars, and faster recovery times. In the realm of orthopedics, these minimally invasive techniques are utilized for various procedures, including arthroscopy, knee and hip joint replacements, and spine fusion.
Further, arthroscopy, specifically, is employed for treating injuries to the shoulder, elbow, wrist, knee, and ankle. The preference for minimally invasive surgeries is particularly evident in the treatment of sports-related injuries. The use of hemostatic products like Dolphin Hemostats during these procedures ensures effective control of bleeding and contributes to the overall success of the surgery. Thus, such trends will shape the growth of the market during the forecast period.
Side effects of bone wax is the major challenge that affects the growth of the market. Bone wax is a traditional hemostatic product utilized for controlling bleeding from bone surfaces. Comprised of beeswax and petroleum jelly, bone wax functions by obstructing blood flow from vessels in the bone without exhibiting any biologic hemostatic effect. However, its use is limited due to the inhibition of bone healing, making it unsuitable for applications where fracture union is necessary. Moreover, bone wax may hinder bacterial clearance from cancellous bone, leading to potential complications in areas of bacterial contamination or infection. Adverse effects associated with bone wax include allergic reactions, granulomatous reactions, and embolization, which refers to the lodging of an embolus within the bloodstream. Despite its limitations, bone wax continues to be an essential tool in orthopedic and trauma surgeries. Oxidized Regenerated Cellulose (ORC) products, such as Dolphin Hemostats, have emerged as potential alternatives to bone wax due to their biocompatibility and hemostatic properties. Hence, the above factors will impede the growth of the market during the forecast period
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abyrx Inc. - The company offers bone wax that consists of two putties that, after hand mixing together for 45 seconds, can be immediately applied to bleeding bone, under the brand name of Abyrx.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The orthopedic surgery segment is estimated to witness significant growth during the forecast period. The market is a significant segment of the medical devices industry, focusing on the prevention and enhancement of bone health. Key players in this market include Asid Bonz, manufacturer of absorbable bone wax, and Hemostax, known for their non-absorbable bone wax. Hospitals and outpatient facilities are the primary consumers of bone wax, used extensively in orthopedic surgeries such as hip arthroplasty and dental or oral surgeries. The Osteoporosis Foundation highlights the importance of bone health, particularly in the aging population, and the role of bone wax in hemostasis during surgeries. Business growth strategies for bone wax manufacturers include mergers, collaborations with pharmaceutical companies, and the production of natural and synthetic bone wax.
Get a glance at the market share of various regions Download the PDF Sample
The orthopedic surgery segment was the largest and wasvalued at USD 24.80 million in 2018. The National Safety Council and emergency departments use bone wax for hemostasis in traumatic injuries, including sports-related injuries and brain injuries. Arthroplasty procedures, such as bipolar coagulation forceps, also employ bone wax for hemostasis. Minimally invasive surgical procedures and neurosurgical applications are emerging areas for bone wax market expansion. Reimbursement and insurance plans play a crucial role in the market's growth, with healthcare players closely monitoring the cost-effectiveness and clinical benefits of bone wax. The Weinstein Legal report emphasizes the importance of adhering to regulatory guidelines for the production and use of bone wax. Overall, the bone wax market is poised for growth, driven by the increasing prevalence of musculoskeletal conditions and the need for effective hemostasis solutions.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 47% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The Bone Wax Market is a significant segment of the medical devices industry, focusing on the prevention and enhancement of bone health. Key players in this market include Asid Bonz, makers of absorbable bone wax, and manufacturers of non-absorbable bone wax like Orthopedic Laboratories, producers of Tableau Wax. Hospitals and outpatient facilities are the primary consumers of bone wax, utilized extensively in orthopedic surgeries such as hip arthroplasty and dental and oral surgeries. Bone wax is essential for hemostasis during surgeries, and its demand is increasing due to the rising number of orthopedic procedures, including arthroplasty and neurosurgical procedures. The Osteoporosis Foundation emphasizes the importance of bone health, particularly in older populations, making bone wax a crucial tool in preventing complications from osteoporosis-related fractures.
In addition, business growth strategies include mergers and acquisitions, with pharmaceutical companies and medical device manufacturers expanding their portfolios to include biotechnological products. The National Safety Council reports that emergency departments treat over 2.5 million sports-related injuries annually, highlighting the need for bone wax in trauma care. High school students and even professional athletes are at risk of sports injuries, making minimally invasive surgical procedures using bone wax a priority for healthcare players. Reimbursement and insurance plans cover the cost of bone wax, ensuring its accessibility to patients. Key products in this market include Bipolar Coagulation Forceps and hemostasis agents like Hemostax. The Weinstein Legal report highlights the importance of proper use and disposal of bone wax to prevent complications and adherence to safety guidelines.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD million" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
You may also interested in below market reports:
The market is witnessing significant growth due to the increasing number of orthopedic and dental surgeries. Bone wax is an essential tool used in surgeries for preventing bone grafts from collapsing or collapsing during surgeries. It is available in two forms: absorbable and non-absorbable. The Osteoporosis Foundation plays a crucial role in promoting bone health awareness, leading to an increase in the number of preventive measures and subsequent surgeries. The market for bone wax is expanding in hospitals and outpatient facilities, driven by the rising number of orthopedic surgeries, such as hip arthroplasty, and dental surgeries. Key players in the bone wax market include Asid Bonz, Hemostax, and Tableau Wax. These companies are focusing on business growth strategies like mergers and collaborations to strengthen their market presence. The market is also witnessing the entry of pharmaceutical, medical devices, and biotechnological products companies.
Additionally, the market is not limited to orthopedic surgeries but also includes neurosurgical procedures, hemostasis, and minimally invasive surgical procedures. The National Safety Council reports that sports-related injuries, arthroplasty procedures, brain injury, and musculoskeletal conditions are significant contributors to the market's growth. The market is also witnessing the use of natural and synthetic bone wax. The Weinstein Legal report highlights the importance of proper usage of bone wax during surgeries to prevent complications. Reimbursement and insurance plans play a crucial role in the market's growth, with the increasing acceptance of bone wax as a necessary tool in surgeries. In conclusion, the bone wax market is poised for growth due to the increasing number of surgeries, awareness of bone health, and the entry of new players. The market's expansion strategies include mergers, collaborations, and the development of natural and synthetic bone wax.
Market Scope |
|
Report Coverage |
Details |
Page number |
140 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.44% |
Market growth 2024-2028 |
USD 19.2 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.17 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 47% |
Key countries |
US, Germany, China, UK, and Canada |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abyrx Inc., B.Braun SE, Baxter International Inc., Bentley Healthcare Pvt. Ltd., Futura Surgicare Pvt. Ltd., GPC Medical Ltd., Healthium Medtech Pvt. Ltd., Henry Schein Inc., Johnson and Johnson Services Inc., Lotus Surgicals Pvt. Ltd., LUXSUTURES, Medline Industries LP, Medtronic Plc, Orion Sutures India Pvt. Ltd., Saintroy Lifescience, Surgical Sutures Pvt. Ltd., Thermo Fisher Scientific Inc., Unisur Lifecare Pvt. Ltd., VWR International LLC, and World Precision Instruments |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.